Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan
Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
J Am Soc Nephrol. 2020 Aug;31(8):1683-1687. doi: 10.1681/ASN.2020040432. Epub 2020 May 5.
A significant fraction of patients with coronavirus disease 2019 (COVID-19) display abnormalities in renal function. Retrospective studies of patients hospitalized with COVID-19 in Wuhan, China, report an incidence of 3%-7% progressing to ARF, a marker of poor prognosis. The cause of the renal failure in COVID-19 is unknown, but one hypothesized mechanism is direct renal infection by the causative virus, SARS-CoV-2.
We performed an autopsy on a single patient who died of COVID-19 after open repair of an aortic dissection, complicated by hypoxic respiratory failure and oliguric renal failure. We used light and electron microscopy to examine renal tissue for evidence of SARS-CoV-2 within renal cells.
Light microscopy of proximal tubules showed geographic isometric vacuolization, corresponding to a focus of tubules with abundant intracellular viral arrays. Individual viruses averaged 76 m in diameter and had an envelope studded with crown-like, electron-dense spikes. Vacuoles contained double-membrane vesicles suggestive of partially assembled virus.
The presence of viral particles in the renal tubular epithelium that were morphologically identical to SARS-CoV-2, and with viral arrays and other features of virus assembly, provide evidence of a productive direct infection of the kidney by SARS-CoV-2. This finding offers confirmatory evidence that direct renal infection occurs in the setting of AKI in COVID-19. However, the frequency and clinical significance of direct infection in COVID-19 is unclear. Tubular isometric vacuolization observed with light microscopy, which correlates with double-membrane vesicles containing vacuoles observed with electronic microscopy, may be a useful histologic marker for active SARS-CoV-2 infection in kidney biopsy or autopsy specimens.
相当一部分 2019 冠状病毒病(COVID-19)患者的肾功能存在异常。对中国武汉 COVID-19 住院患者的回顾性研究报告称,有 3%-7%的患者进展为急性肾损伤(ARF),这是预后不良的标志。COVID-19 患者发生肾衰竭的原因尚不清楚,但有一个假设的机制是致病病毒 SARS-CoV-2 直接感染肾脏。
我们对一名因主动脉夹层修复术后并发低氧性呼吸衰竭和少尿性肾衰竭而死于 COVID-19 的患者进行了尸检。我们使用光镜和电子显微镜检查肾组织中是否存在 SARS-CoV-2 感染肾细胞的证据。
近端肾小管的光镜检查显示出局灶性等距空泡化,对应于大量细胞内病毒排列的肾小管焦点。单个病毒的平均直径为 76 毫微米,其包膜上布满冠状、电子致密的刺突。空泡内含有双层膜囊泡,提示部分组装的病毒。
肾管状上皮细胞中存在与 SARS-CoV-2 形态完全一致的病毒颗粒,且具有病毒排列和其他病毒组装特征,这为 SARS-CoV-2 直接感染肾脏提供了证据。这一发现为 COVID-19 急性肾损伤(AKI)中存在直接肾感染提供了确证性证据。然而,直接感染在 COVID-19 中的频率和临床意义尚不清楚。光镜下观察到的管状等距空泡化与电子显微镜下观察到的含有空泡的双层膜囊泡相关,这可能是肾活检或尸检标本中 SARS-CoV-2 感染的有用组织学标志物。